Trademark: 88983683
Word
FAX PHARMA
Status Date
Tuesday, March 15, 2022
Registration Number
6673025
Registration Date
Tuesday, March 15, 2022
Filing Date
Tuesday, January 28, 2020
Published for Opposition
Tuesday, May 11, 2021
42 Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Quality evaluation services for the medical and anesthesia industries; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific investigations for medical purposes; Scientific research; Scientific research and development
The mark consists of the stylized wording "FAX" which has two colors; the "FA" is in blue, and the "X" is in red with blue lines inside the "X" to make it appear as if the "X" is a DNA strand. The stylized wording "pharma" appears below the stylized wording "FAX" in gray lettering.
FAX PHARMACY
The color(s) blue, red, and gray is/are claimed as a feature of the mark.
"PHARMA"
Mar 15, 2022
Registered-Principal Register
Feb 8, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 7, 2022
Allowed Principal Register - Sou Accepted
Jan 21, 2022
Notice Of Design Search Code E-Mailed
Jan 20, 2022
Statement Of Use Processing Complete
Jan 6, 2022
Use Amendment Filed
Jan 20, 2022
Divisional Processing Complete
Jan 6, 2022
Divisional Request Received
Jan 20, 2022
Case Assigned To Intent To Use Paralegal
Jan 6, 2022
Teas Request To Divide Received
Jan 6, 2022
Teas Statement Of Use Received
Jul 6, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 2, 2021
Changes/Corrections After Pub Approval Entered
Jul 1, 2021
Assigned To Petition Staff
May 27, 2021
Teas Post Publication Amendment Received
May 11, 2021
Official Gazette Publication Confirmation E-Mailed
May 11, 2021
Published For Opposition
Apr 21, 2021
Notification Of Notice Of Publication E-Mailed
Apr 7, 2021
Approved For Pub - Principal Register
Apr 6, 2021
Teas/Email Correspondence Entered
Apr 6, 2021
Correspondence Received In Law Office
Mar 30, 2021
Assigned To Lie
Mar 24, 2021
Teas Request For Reconsideration Received
Mar 8, 2021
Notification Of Final Refusal Emailed
Mar 8, 2021
Final Refusal E-Mailed
Mar 8, 2021
Final Refusal Written
Feb 18, 2021
Teas/Email Correspondence Entered
Feb 18, 2021
Correspondence Received In Law Office
Feb 18, 2021
Assigned To Lie
Nov 25, 2020
Notice Of Revival - E-Mailed
Nov 25, 2020
Teas Response To Office Action Received
Nov 25, 2020
Petition To Revive-Granted
Nov 25, 2020
Teas Petition To Revive Received
Nov 16, 2020
Abandonment Notice E-Mailed - Failure To Respond
Nov 16, 2020
Abandonment - Failure To Respond Or Late Response
Apr 23, 2020
Notification Of Non-Final Action E-Mailed
Apr 23, 2020
Non-Final Action E-Mailed
Apr 23, 2020
Non-Final Action Written
Apr 16, 2020
Assigned To Examiner
Feb 4, 2020
Notice Of Design Search Code E-Mailed
Feb 3, 2020
New Application Office Supplied Data Entered In Tram
Jan 31, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
